“Kennedy is not anti-vaccine,” Redfield wrote in a letter to senators earlier this week. “His inquiries prove he’s more science-oriented than many of his critics.” ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...

Postmarketing reports indicate 17 serious adverse events have been reported in vaccine recipients 62 to ... for Disease Control and Prevention (CDC). According to the Agencies, as of May 7 ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

Aerial view of a palm fringed beach on Waya Island in the Yasawa Islands of Fiji. 33,608 people played the daily Crossword recently. Can you solve it faster than others?33,608 people played the ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who received the Ixchiq chikungunya vaccine. The FDA and the Centers for Disease ...

Hold off on inoculating people ages 60 and older against chikungunya infection with the Ixchiq vaccine, the FDA and CDC jointly recommended amidst an investigation into adverse events. Two ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...